chrisvoncsefalvay/vaers-outcomes huggingface dataset:
FEELING UNWELL; This spontaneous report received from a patient concerned an elderly female. The patient's height, and weight were not reported. The patient's concurrent conditions included moderate to severe rheumatoid arthritis. The patient received covid-19 vaccine (suspension for injection, intramuscular, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced feeling unwell. The action taken with covid-19 vaccine was not applicable. The outcome of feeling unwell was not reported. This report was non-serious.
Nausea; shortness of breath; tiredness; stiffness at the injection site; stiffness at the injection site; This is a spontaneous report from a contactable consumer. A 33-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection (lot numbers and expiry dates were unknown) via an unspecified route of administration on 08Dec2020 for the first dose and on 08Jan2021 for the second dose, both administered in the right arm at a single dose for COVID-19 immunization. The patient had no medical history and no concomitant medications. The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to BNT162B2 and did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Jan2021, the patient experienced nausea, shortness of breath, tiredness, and stiffness at the injection site. No therapeutic measures were taken in response to the events. Outcome of the events at the time of last observation was recovered. The report was considered as non-serious; the events did not result in death, were not life threatening, did not caused/prolonged hospitalization, were not disabling/ incapacitating, and did not caused any congenital anomaly/birth defect.  Information on the lot/batch number has been requested.
Local reaction within few days following anthrax vaccine (red, tender, swollen sub-q knot).
got the shot and had them/Suspected Vaccination Failure; had them; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: got the shot and had them/Suspected Vaccination Failure) (serious criteria GSK medically significant) and shingles (Verbatim: had them). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 22-APR-2023 The case  was received from the patient' sister/brother via interactive digital media. The patient got the shot and had them really bad a few years ago. The reporter stated that they say vaccine was different now. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Pt inadvertently was given two doses of Menactra at the same administration in each arm. Had one of her injections 2 days later but no other adverse events.
Information has been received from the VAERS database via a journalist. This spontaneous report as received from a regulatory authority refers to a patient of unknown age. The patient was vaccinated with lot # (656609/0015U) ZOSTAVAX on 23-APR-2007. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient experienced herpes zoster. No treatment information was reported. The outcome of herpes zoster is unknown. The relatedness for herpes zoster is unknown for ZOSTAVAX. Additional information is not expected.
His brother reporting that he got the vaccine, the following day he was coughing.  The coughing caused him not to be able to sleep and was weak due to that.  He could feel his throat closing and he was having a hard time breathing and he called his brother who told him to call 9-1-1.  He was taken to Medical Center 4/17/2021, diagnosed with possibly COVID.   He was admitted to the COVID ward and he died on 4/26/2021.   The doctor that pronounced him was .   Cause of death diagnosis.  Hypoxic respiratory arrest, COVID 19
Pain; Head was hurting; I thought was like cold coming up; This is a spontaneous report from a contactable consumer(patient). A patient of unspecified gender and age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/lot number: Unknown, Expiry Date: Unknown) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization: Paracetamol (TYLENOL, Lot number: unknown, Expiry date: Not reported) via an unspecified route of administration on an unknown date unknown dose and frequency for pain killer and unknown if ongoing. The patient medical history and concomitant medications were not reported. It was reported that on an unspecified date patient experienced Pain. Patient stated "I had a (Pfizer, Covid-19) Vaccine shot 2 days ago, I took a Tylenol pain killer (might have pain after shot) yesterday (24Mar2021). Reporter queried that would that effect. "I took some, my head was hurting, so I took Robitussin and I thought was like cold coming up" on an unspecified date. Therapeutic measures were taken as a result of the events Pain, Head was hurting. Outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Hit an artery while administering vaccine. No pre-aspiration, just injected. High in the shoulder, 1" from top of shoulder, in line with shoulder joint. Unknown if injection was IM or venous.  Immediate bleeding and bruising. Stopped with direct pressure. Pain within the next hour. 1.5" bullseye bruise developed. Significant pain for 3 days. Tylenol. Pain on 4th day is minimal. Bruise will take a while to disappear.
5-10 minutes after receiving third series of shots while parents were putting child in car seat in waiting room, child's legs both upper and lower experienced red flushing which spread to her face.  Removed from car seat and returned to clinic area for observation and possible treatment.  Heart rate 172 Lungs clear and no respiratory difficulty.  Child was crying but able to be comforted by parents.  911 called and transported to hospital.  Parents disclosed to paramedics that child had received eggs for the first time 4/14/08 45 minutes prior to immunization appointment.  Later determined that child's grandfather has an egg allergy as well.  In follow up telephone conversation with father today, no treatment was rendered at hospital ER.  Parents were instructed not to give an eggs until after 12 months of age and follow up with primary physician.  Redness eventually disappeared. Parents plan to follow up with primary care physician.  Concerned about further vaccinations.  Advised that none of vaccines administered were derived from egg.  Advised no flu vaccine at this time.
Client c/o metallic taste in the mouth and slight headache.  Client denies any other symptoms at the moment.  Client seen and assessed by EMT and vital signs are: BP 185/4, HR 84, O2 98.  Client voiced that she had taken her medication and not eaten.  By 9:50 am, client voiced that she had felt better and cleared to go home by EMT.
My symptoms started on December 04, 2022 I experienced rash, itchiness, redness around eyes, redness and itchiness around the elbows. I was prescribed steroids for my symptoms.
Information has been received from a registered nurse (R.N.) referring to an unknown number of patients of unknown age and gender. No relevant medical history or concurrent conditions were reported. On unknown dates these patients were vaccinated with PNEUMOVAX 23 single dose vials (lot # K007826, expiration date 03-FEB-2016; dose and route not reported) that had been improperly stored. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Within 5 or so minutes of injection - Waves of warmth and nausea. Very slight tingling in throat. Slightly elevated heart rate. Dehydration. Treated with benedryl and drank a lot of water and gatorade. Symptoms continued through next day. Body aches within 24 hours of vaccine in addition to tenderness at site of shot.
Pt experienced pain for 12 days, the pt missed school for 2 of those days. Pt couldn't move arm due to pain in shoulder (left) until today. Pt did not seek medical care because they did not have insurance.
Temperature of 100.1F, chills, fatigue, soreness at the injection site (is ok now). Still did not recover my sense of smell or taste after having COVID in the beginning of the month.
Client reports painful, white sores in her mouth and on her tongue, beginning on 2/27 and lasting for about "10 days after."  She did not take her Orencia for RA on 2/27 due to these symptoms and reports that by 3/3/21 (Wednesday), "I was having a full blown flare of my RA with joint pain and fatigue; I noticed the worst symptoms in my wrists and hands." This prompted patient to take her Orencia on 3/3 that week. Due to the mouth sores, she increased her acyclovir (Zovirax) to 400mg BID. Client reports that after her 2nd dose on 3/24, she developed a "severe headache" the next day with worsening  of "just feeling really bad" noting that mouth sores returned on 3/27/21 and that on 3/28/21, "I woke up with something that felt like a bug bite on my left side" described as in the area of her lateral trunk region. She states, "I saw my RA doctor on 3/29 and was diagnosed with Shingles. She has prescribed Valtrex 1g TID on 3/29 and I still have the rash."
my heart wasn't working as well it caused me to pass out; migraines; affected my heart rate and made my heart weaker; This spontaneous case was reported by a patient and describes the occurrence of SYNCOPE (my heart wasn't working as well it caused me to pass out) in an adult patient of an unknown gender who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced SYNCOPE (my heart wasn't working as well it caused me to pass out) (seriousness criterion medically significant), MIGRAINE (migraines) and CARDIAC DISORDER (affected my heart rate and made my heart weaker). At the time of the report, SYNCOPE (my heart wasn't working as well it caused me to pass out) and CARDIAC DISORDER (affected my heart rate and made my heart weaker) outcome was unknown and MIGRAINE (migraines) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: irregular.     The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.       Concomitant medication not reported.   The patient got vaccine it affected heart rate and made heart weaker. Patient was doing an activity one day and because heart wasn't working it as well caused patient to pass out and hit head really hard and patient getting constant migraines.  Treatment medication not reported.   Company Comment This spontaneous case concerns adult patient of an unknown gender with no medical history reported who experienced the seriousness criterion medically significant unexpected event of syncope; the unexpected events of migraine and cardiac disorder unknown days after a dose of mRNA-1273.815 vaccine.  Concomitant medication details nor Treatment details were reported. At the time of the report, the events had not resolved. The benefit-risk relationship of mRNA-1273.815 vaccine is not affected by this report.
Immediate soreness around the injection site and mild pain radiating down right arm. Slowly over time, pain began to worsen and expand down into fingertips, down side and up my neck. By 5pm, experienced severe shooting pain up and down right side, left arm and inability to move neck to the right. Severe tightness of neck muscles, back and arm on right side making movement difficult. Diarrhea, mild confusion, increased heart rate, body aches strong enough to release urinary muscles, chills, and headache. Pain level 8/10. Morning after (almost 24hrs past injection) still shooting pain down both arms, tightness in neck, arm and back, shooting pain down right side to all extremities, nausea, and headache.
Mistakenly Injected SC.  I called to check on patient a pt reports redness and that it is a little sore
5 minutes post administration, patient endorsed itching at administration site and itching down her entire arm. She said she felt like her neck was swelling. She was able to speak, denied difficulty breathing. She was given 50mg PO benadryl. Paramedics were called. She was found to be hypertensive and tachy, oxygenating fine, alert and oriented. She refused transport to hospital for evaluation.
This case was reported by a pharmacist via call center representative and described the occurrence of rash in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX (subcutaneous). On an unknown date, unknown after receiving SHINGRIX, the patient experienced rash and intramuscular formulation administered by other route. On an unknown date, the outcome of the rash and intramuscular formulation administered by other route were unknown. It was unknown if the reporter considered the rash to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The healthcare professional (HCP) reported that his patient received SHINGRIX at another pharmacy and it was given subcutaneously, which led to incorrect route of product administration. Following administration, the patient experienced rash 4 to 6 diameters in size. The HCP did not give consent to follow up. The HCP was unable to provide lot number, expiry date or patient demographics.
HEART RACING SENSATION; ANXIOUS MOOD; Nausea; This is a spontaneous report from a contactable Healthcare Professional. A 67 years old male patient received BNT162B2 (COMIRNATY; Lot Number: EN6207), via an unspecified route of administration on 15Mar2021 (at an age of 67 years old), as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Its unknown whether Prior to the vaccination, the patient was diagnosed with Covid-19 or not. On 15Mar2021, the patient experienced slight nausea, heart racing and also was in anxious mood during the 15 minutes waiting period after the injection (vaccination). Patient denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness and hoarseness. Patient did not receive any treatment for the adverse events. Patient was stable to go home and agreed for follow up with PCP. The clinical outcome of event slight nausea, anxious mood and heart racing were not reported. No follow-up attempts are needed. No further information is expected.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Hypotension-Medium, Systemic: Nausea-Medium, Systemic: Seizure-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Systemic: Visual Changes/Disturbances-Medium, Additional Details: Patient had a history of seizures from 2012-2015 but is no longer on medication of any sort.  About 5-7 min after vaccine was given he had seizure like activity.  He had cold sweats, low blood pressure, and was very pale.  He complained of dizziness, nausea, tingling in hands, and blurred vision.  911 was called and he left with EMT
Flu Like Symptoms; Tiredness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu Like Symptoms), FATIGUE (Tiredness) and HEADACHE (Headache) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No medical history was reported.     On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu Like Symptoms), FATIGUE (Tiredness) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (Flu Like Symptoms), FATIGUE (Tiredness) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant  information was  provided.
Patient received the covid vaccine on 12/22/2020.   On 12/23/2020  at 3:00 am, she was awakened in the middle of night with a "bad" headache and feeling "chills". No fever. Felt better the next day, 12/24/20 but noted left neck lymph node swelling. No sore throat or cough.  No problem swallowing.  On 12/28/2020 chills recur, L neck lymph node is enlarged. Sxs persist until today. Had covid testing on 12/28/2020 with PCP. Waiting result.
At 11:20 AM on 8/20/10 client received the immunizations (listed) below. Client talking and answering questions prior to, during and after vaccinations. Approx. 10 mins. after her vaccinations she said she was "feeling funny". No c/o's vertigo, HR=76, nausea, h/a, etc. Felt better after approx. 15 min. and left office walking on her own accomp. by her mother.
Body aches; hand plus thumb ache even stronger; This is a spontaneous report from a contactable consumer (patient). A 70-year-old non pregnant female patient received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: not reported, Expiry date: not reported, age at of 70-year-old), via an unspecified route of administration, administered in left arm on 15Feb2021 13:00 as dose 2, single for covid-19 immunisation. Medical history included arthritis (diagnoses in the affected thumb and wrist). The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiry date: unknown, at age of 70-year-old), via an unspecified route of administration in left arm on 25Jan2021 16:00 as dose 1, single for covid-19 immunisation. The patient concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks to vaccine. It was unknown if patient received other medication in two weeks. On 16Feb2021, the patient experienced body aches, and hand plus thumb ache even stronger than body ache. The outcome of event was recovered on an unspecified date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Vaccination adverse reaction; This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (Vaccination adverse reaction) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (Vaccination adverse reaction). At the time of the report, IMMUNISATION REACTION (Vaccination adverse reaction) outcome was unknown.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown) was unknown.       Concomitant medications were not reported.  It was reported that, patient forced to take experiment against patient will, and it had adverse impacts. Patient was asking for compensation otherwise patient reported that, patient will seek other resources. Treatment medications were not reported.
Pt experiencing arm pain. 7 days after vaccination. Pain in shoulder. Unable to raise arm above head.
THE PATIENT CALLED AND SAID HE BROKE INTO HIVES AND DEVELOPED RASHED ON HIS FACE, NECK AND SHOULDERS AND FELT LIKE HE HAD SOME ACHES AND PAINS SINCE LAST NIGHT.
Patient received Moderna vaccine (1st dose) at 4:41 pm and was advised to stay in observation for 30 minutes due to prior severe reaction to a medication. At 4:50 pm, patient c/o sweating and tachycardia. Patient was offered and accepted water and VS were taken with BP162/98, HR 113, and O2 Sat of 100%. Patient admitted to having history of anxiety. Patient was instructed to take slow deep breaths.  At 5:00 pm, BP was 138/89, HR  94, and O2 sat of 100%.  Patient stated feeling better and stated she was comfortable to go home.  After 30 minute observation period, patient was advised to call 911 if symptoms got worse and if she developed any other severe reactions.
1. Very large red, warm to the touch swelling at the injection site which extended to the inner arm 2. Moderate Itchy rash on the right fore arm -  occurred 2 day after the vaccine; lasted approximately 4 days - required hydrocortisone cream. 3. Large Itchy rash on the inner thigh area extending to the vaginal area -  occurred approximately 6 days later; still persistent after Benadryl and hydrocortisone cream.
rash under tongue. little pouches under tongue and lower lip; difficult to eat and cannot wear lower dentures; This spontaneous case was reported by a consumer and describes the occurrence of TONGUE ERUPTION (rash under tongue. little pouches under tongue and lower lip) and DYSPHAGIA (difficult to eat and cannot wear lower dentures) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Denture wearer. Concomitant products included TAMSULOSIN, APIXABAN (ELIQUIS) and LISINOPRIL for an unknown indication.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Mar-2021, the patient experienced TONGUE ERUPTION (rash under tongue. little pouches under tongue and lower lip) and DYSPHAGIA (difficult to eat and cannot wear lower dentures). At the time of the report, TONGUE ERUPTION (rash under tongue. little pouches under tongue and lower lip) and DYSPHAGIA (difficult to eat and cannot wear lower dentures) outcome was unknown.
ShinglesTwo trips to ER for severe back and side pain. Test run for suspected heart attack first time. Second trip doctor recognized symptoms and checked back for rash. Prescribed pain med and antiviral and released to go home. Still have rash. Pain first began 11 days ago, rash appeared four days later.
4 papular lesions & redness developed around Varicella inject site, no fever.